EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiation for Acute Severe Ulcerative Colitis: A Case Series in the United States

Rahul S Dalal iD, Rachel W Winter, Sanchit Gupta, Gila F Sasson, Matthew J Hamilton, Jessica R Allegretti

Inflammatory Bowel Diseases · 03.06.2024 · 30 (6) · 1042-1043

DOI: 10.1093/ibd/izae038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 26.02.2024. Verfasst von Rahul S Dalal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Heterocyclic Compounds, 3-Ring. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lay Summary In 9 patients hospitalized for acute severe ulcerative colitis, 8 were successfully discharged without the need for colectomy. Six of 7 patients with sufficient follow-up achieved steroid-free clinical remission at 8 to 16 weeks, and 1 of 2 patients achieved endoscopic response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeHeterocyclic Compounds, 3-RingHumansMaleFemaleAdultUnited StatesMiddle AgedTreatment OutcomeSeverity of Illness IndexAcute Disease

Substanzen

upadacitinibHeterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Rahul S Dalal

Zitieren

APA

Dalal, R. S., Winter, R. W., Gupta, S., Sasson, G. F., Hamilton, M. J., & Allegretti, J. R. (2024). Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiation for Acute Severe Ulcerative Colitis: A Case Series in the United States. Inflammatory Bowel Diseases, 30(6), 1042-1043. https://doi.org/10.1093/ibd/izae038

Vancouver

Dalal RS, Winter RW, Gupta S, Sasson GF, Hamilton MJ, Allegretti JR. Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiation for Acute Severe Ulcerative Colitis: A Case Series in the United States. Inflammatory Bowel Diseases. 2024;30(6):1042-1043. doi:10.1093/ibd/izae038

BibTeX
@article{Dalal2024,
  author = {Dalal, Rahul S and Winter, Rachel W and Gupta, Sanchit and Sasson, Gila F and Hamilton, Matthew J and Allegretti, Jessica R},
  title = {Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiation for Acute Severe Ulcerative Colitis: A Case Series in the United States},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  volume = {30},
  number = {6},
  pages = {1042--1043},
  doi = {10.1093/ibd/izae038}
}
Kostenlos starten →